Keywords: Anti-obesity drugs, Lack of attractive products, Globaldata

More investment needed in anti-obesity drugs to appeal to growing market, says GlobalData report

Article | 11 March 2012

Pharmaceutical companies should increase their investment in anti-obesity drug therapies to support the growing number of clinically obese individuals worldwide, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in